Company news

Proteome Sciences plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Appointment of Non-Executive Director

September 16, 2026

Further GCLP Chemoproteomics contract secured

September 15, 2026

Target engagement/chemoproteomics contract

June 22, 2026

Annual General Meeting Statement

May 14, 2026

Final results for the year ended 31 December 2025

April 15, 2026

Holding(s) in Company

February 4, 2026

Result of Oversubscribed Retail Offer

January 28, 2026

Retail Offer to raise up to £60,000

January 26, 2026

Two Further Substantial Contracts for PRM

January 6, 2026

Substantial contract for Proteome Sciences

December 8, 2025

Appointment of Nominated Adviser and Broker

November 25, 2025

Interim Results

September 25, 2025

HSBC holdings plc announces results of its tender offers for four series of notes

September 9, 2025

Result of AGM

May 16, 2025

Final Results

April 10, 2025

Notice of Results and Investor Presentation

April 4, 2025

Contract Win

February 21, 2025

Loan Facility, Trading Update & Directorate Change

December 23, 2024

Interim Results and Directorate Change

September 13, 2024

AGM Statement

May 16, 2024

Completion of new facility in San Diego

January 2, 2024

Trading Update

November 30, 2023

Launch of Single Cell Proteomics Services

October 2, 2023

Investor Presentation

August 30, 2023

Repayment of Loan

June 1, 2023

Expansion into the US

May 12, 2023

Director/PDMR Shareholding

April 14, 2023

Notice of Results

March 29, 2023

Price Monitoring Extension

March 6, 2023

Milestone Payment for TMT®/TMTproT Sales

January 5, 2023

Grant of Options and PDMR/director shareholdings

December 1, 2022

Change of Auditor

October 4, 2022

Second Price Monitoring Extn

September 20, 2022

Appointment of Chief Financial Officer

August 18, 2022

Milestone towards Single Cell Proteomics services

August 3, 2022

Change of Registered Office

May 26, 2022

Substantial Contract Win

May 12, 2022

Director shareholding

April 1, 2022

Loan amendment

March 30, 2022

PRM,INmune Bio presenting biomarker discovery data

November 5, 2021

Issuance of key TMT Patent

May 19, 2021

Loan Amendment

March 30, 2021

Trading Update and Notice of Results

March 26, 2021

Year End Trading Update

January 25, 2021

Appointment of Chief Executive Officer

September 14, 2020

Notice of Annual General Meeting

June 2, 2020

Response to Share Price Movement

April 28, 2020

Posting of Results, AGM update and loan amendment

April 20, 2020

Further Year End Trading Update, Milestone Payment

February 11, 2020

Trading Update and Announcement of Board Changes

October 31, 2019

Older news releases →

Calls

The 5 newest of 7 calls. Every call is listed under its year.

Decks